The remit of the Hepatology Specialty Group is to support a national portfolio of structured research studies in the field of liver disease. One of the main purposes of the Specialty Group is to ensure that clinical research studies in Hepatology deliver to target by developing and supporting a research infrastructure within the specialty which promotes engagement of the Gastroenterology and Hepatology communities and provides the local support necessary to undertake high quality research studies within the NHS.
The Hepatology Specialty Group will work closely with the British Society of Gastroenterology, British Association for the Study of the Liver and other stakeholders, to ensure that new developments in the field of liver disease research are informed by a national clinical research strategy and can be successfully delivered in the NHS setting.
Specialty Group Lead: Dr Daniel Forton
Dr Daniel Forton BSc, PhD, MBBS, FRCP is a Consultant Hepatologist and Gastroenterologist and Honorary Senior Lecturer at St. George's Healthcare NHS Trust.
He qualified at University College London and trained in Gastroenterology, Hepatology and General Medicine at St Mary's, Charing Cross and Hammersmith Hospitals, London.
During his training he was appointed as a Research Fellow and subsequently, as a Clinical Lecturer at Imperial College London, performing scientific research and clinical trials in the area of viral hepatitis. He was awarded a PhD from Imperial College London in 2004 and the Dame Sheila Sherlock Research Medal from the British Association for the Study of the Liver.
His current research interests include clinical trials in liver disease, including new antiviral regimens for hepatitis B and C, predictors of interferon induced depression/cognitive dysfunction and mechanisms of viral persistence in chronic hepatitis.
Visit the National Hepatology Specialty Group web page for further information.
